Ritlecitinib alone or with narrow-band UVB phototherapy well tolerated and beneficial in nonsegmental vitiligo

Interest in cosmetic procedures significantly predicted by frequent self-viewing behavior

In study, authors describe only two cases of local recurrence among 148 tumors managed by watchful waiting after clinical resolution

Efficacy and safety for scalp psoriasis, seen at week 16, are maintained through week 52

More localized VLD seen in study cohort; 140 of 200 patients had less than 10 percent of body surface area affected

Increased risk seen in association with nine primary cancers, with highest risk at one to five years after diagnosis of primary cancer

CLICK HERE to watch Dr James Del Rosso give his expert clinical insights on VTAMA for atopic dermatitis

Additionally, interim analysis shows that the antiviral is safe but has no effect on pain among adults with mild-to-moderate clade II mpox

CLICK HERE to watch Dr James Del Rosso’s dermatologic deep dive on Bimzelx (bimekizumab) for psoriatic arthritis

The monoclonal antibody treatment is for patients ages 12 years and older

CLICK HERE to watch Dr James Del Rosso provide an in-depth overview of Nemluvio (nemolizumab) for atopic dermatitis

Self-guided cognitive behavioral therapy intervention noninferior to clinician-guided therapy

Risk factors for subsequent neoplasm risk include age 50 years and older at BMT, male sex, post-BMT immunosuppression

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

• EFFICACY: In...

Findings for primary tumors of 0.8 to 1.0 mm versus those <0.8 mm

All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM

Findings seen for children with and without comorbidities, such as asthma, allergic rhinitis, food allergies

Significantly lower risks for melanoma, lung cancer, bladder cancer seen for patients with vitiligo

TMB significantly associated with older age at diagnosis, history of nonmelanoma skin cancer, head and neck tumors

Risk 25 percent higher when comparing matched individuals with and without celiac disease

Older age, female sex, and allergic comorbidities increase risk for developing Meniere disease

Safety profile consistent, clinical response durable among patients with moderate-to-severe plaque psoriasis